← FDA Drug Approvals (Drugs@FDA)
PREGABALIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-07-19
Drug application
- FDA Application #
ANDA208677- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PREGABALIN
- Generic name
- PREGABALIN
- Active ingredients
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc
- First approval
- 2019-07-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown